Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-α

Revista de Investigacion Clinica

Volumn 54, Issue 1, 2002, Pages 41-50

  Alvarado Esquivel, Cosme ^a   Elewaut, André ^a   Philippé, Jan ^a   Elewaut, Ann E ^a   Desombere, Isabelle ^a   Maertens, Geert ^a   Leroux Roels, Geert ^a  

^a Inst de Investigacion Cientifica   (Mexico)

Author keywords

Chronic hepatitis C; Cytokines; Interferon alpha; T cell epitopes; Therapy

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; RECOMBINANT ALPHA2B INTERFERON; TUMOR NECROSIS FACTOR ALPHA; VIRUS ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULAR EVOLUTION; MULTICENTER STUDY; PROTEIN BLOOD LEVEL; T LYMPHOCYTE;

ADULT; AGED; ANTIVIRAL AGENTS; BIOLOGICAL RESPONSE MODIFIERS; CELLS, CULTURED; CULTURE MEDIA; FEMALE; HEPATITIS C ANTIGENS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON TYPE II; INTERFERON-ALPHA; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; VIRAL CORE PROTEINS;

EID: 0036233032     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Hepatitis B and C virus infections in Mexico: Genotypes and geographical distribution in blood donors and patients with liver disease
2. Natural history and clinical aspects of hepatitis C virus infection
3. Apoptosis and pathogenesis of viral hepatitis C - An update
4. Risk of developing hepatocellular carcinoma according to the titer of antibody to hepatitis C virus
5. Current treatment strategies for chronic hepatitis B and C
6. Benelux multicentre trial of alpha interferon treatment for chronic hepatitis C: Standard v high dose treatment monitored by biochemical and virological markers
7. Treatment of chronic hepatitis C with interferon: 1998 update
8. Biological basis for the clinical use of interferon
9. Immunity to viruses, bacteria and fungi
10. Lymphoproliferative responses to hepatitis C virus core, E1, E2 and NS3 in patients with chronic hepatitis C infection treated with interferon alpha
11. La respuesta inmunitaria
12. Inmunología de la hepatitis C
13. Cytokines in viral hepatitis
14. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay
15. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
16. Genetic organization and diversity of the hepatitis C virus
17. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C
18. Role of the specific T-cell response for clearance and control of hepatitis C virus
19. Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma
20. Production of cytokines in patients infected by hepatitis C virus
21. Increased frequency of interferon-gamma-producing peripheral blood CD4+ T cells in chronic hepatitis C virus infection
22. IL-1 beta and TNF-alpha produced by peripheral blood mononuclear cells before and during interferon therapy in patients with chronic hepatitis C
23. Treatment with ribavirin and interferon-alpha reduces interferon-gamma expression in patients with chronic hepatitis C
24. Serum levels of cytokines in hepatitis C-related liver disease: A longitudinal study
25. Serum cytokine values and fatigue in chronic hepatitis C infection
26. Predictors of sustained response to alpha interferon therapy in chronic hepatitis C
27. Intrahepatic expression of interleukin-1beta and tumor necrosis factor-alpha in chronic hepatitis C
28. Liver infiltrating T lymphocytes express interferon gamma and inducible nitric oxide synthase in chronic hepatitis C virus infection
29. Virus-specific CD8(+) T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection
30. Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection
31. Characterization of liver T-cell receptor gammadelta T cells obtained from individuals chronically infected with hepatitis C virus (HCV): Evidence for these T cells playing a role in the liver pathology associated with HCV infections
32. Lack of evidence for the Th2 predominance in patients with chronic hepatitis C
33. Decreased frequency of HCV core-specific peripheral blood mononuclear cells with type 1 cytokine secretion in chronic hepatitis C
34. Different cytokine profiles of peripheral blood mononuclear cells from patients with persistent and self-limited hepatitis C virus infection